» Authors » Mohammad-Taghi Bahreyni-Toossi

Mohammad-Taghi Bahreyni-Toossi

Explore the profile of Mohammad-Taghi Bahreyni-Toossi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 21
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Darvish L, Bahreyni-Toossi M, Aghaee-Bakhtiari S, Akbari-Naserkiadeh A, Vaziri-Nezamdoust F, Azimian H
Gene . 2024 Sep; 933:148951. PMID: 39303820
Despite the success of radiotherapy for prostate cancer treatment, the recent discovery of radiation resistance prevents it from reaching its full potential. This study aims to use hsa-miR-7-5p for the...
2.
Mollaee P, Azimian H, Ghadim N, Dolat E, Sheykhoo A, Bahreyni-Toossi M
J Cancer Res Ther . 2024 Feb; 19(Suppl 2):S737-S742. PMID: 38384048
No abstract available.
3.
Kosarnia M, Bahreyni-Toossi M, Gholamhosseinian H, Dolat E, Fakour-Mollaee P, Azimian H
Radiat Prot Dosimetry . 2023 Jul; 199(13):1410-1415. PMID: 37448196
Radiation during radiotherapy and nuclear accidents is currently one of the biggest concerns for the international community. Biological dosimetry examines the amount of damage caused by radiation at the cellular...
4.
Darvish L, Bahreyni-Toossi M, Aghaee-Bakhtiari S, Firouzjaei A, Amraee A, Tarighatnia A, et al.
Mol Biol Rep . 2023 Jun; 50(7):6063-6074. PMID: 37294470
Background: One of the problems with radiation therapy (RT) is that prostate tumor cells are often radio-resistant, which results in treatment failure. This study aimed to determine the procedure involved...
5.
Bahreyni-Toossi M, Dayyani M, Mahmoudi M, Azimian H
Iran J Basic Med Sci . 2022 Oct; 25(9):1104-1109. PMID: 36246068
Objectives: To enhance the efficiency of radiotherapy (RT), implementation of individual-based treatment is essential. In this way, determining individual intrinsic radiosensitivity (IRS) can be useful to achieve minimal adverse effects...
6.
Farhadi S, Bahreyni-Toossi M, Zafari-Ghadim N, Khademi S, Sadat-Darbandi M, Azimian H
Mutat Res Genet Toxicol Environ Mutagen . 2022 Aug; 881:503528. PMID: 36031334
The adaptive response (AR), which can be induced by low-dose ionizing radiation (LD), may influence the therapeutic ratio of cancer treatment. We investigated the AR and the DNA double-strand break...
7.
Bahreyni-Toossi M, Azimian H, Aghaee-Bakhtiari S, Mahmoudi M, Sadat-Darbandi M, Zafari N
Mutat Res . 2021 Aug; 823:111760. PMID: 34390933
Purpose: Radiotherapy plays a pivotal role in the treatment of cancer. One of the main challenges in this treatment modality is radiation-induced complications in some patients affected by high radiosensitivity...
8.
Bahreyni-Toossi M, Sankian M, Azimian H, Najafi-Amiri M, Khademi S, Abdollahi-Dehkordi S, et al.
J Cancer Res Ther . 2021 Jun; 17(2):537-542. PMID: 34121704
Introduction: In the present study, the radioadaptive role of the immune system induced by low dose (LD) was investigated for its in vivo protective activity. Materials And Methods: Quantitative analysis...
9.
Bahreyni-Toossi M, Zafari N, Azimian H, Mehrad-Majd H, Farhadi J, Nezamdoust F
Cancer Biother Radiopharm . 2020 Aug; 38(8):506-511. PMID: 32833505
Radiotherapy is a crucial component of treatment for ∼70% of all cancer patients. The identification of effective biomarkers of radiosensitivity (RS) is a fundamental goal of radiobiology. The authors hypothesize...
10.
Vosoughi H, Azimian H, Khademi S, Rezaei A, Najafi-Amiri M, Vaziri-Nezamdoost F, et al.
Iran J Basic Med Sci . 2020 Jun; 23(4):449-453. PMID: 32489559
Objectives: Nowadays, ionizing radiation (IR) has a significant contribution to the diagnostic and therapeutic medicine, and following that, health risks to individuals through unexpected exposure is greatly increased. Therefore, biological...